Mesa Laboratories
MLAB
169 hedge funds and large institutions have $1.01B invested in Mesa Laboratories in 2020 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 67 increasing their positions, 35 reducing their positions, and 9 closing their positions.
278% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 9
246% more capital inflows, than outflows
Capital inflows: $167M | Capital outflows: $48.3M
91% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 35
17% more funds holding
Funds holding: 144 → 169 (+25)
3.35% less ownership
Funds ownership: 95.15% → 91.8% (-3.4%)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.4M |
| 2 |
Goldman Sachs
New York
|
+$21M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$14.2M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$9.8M |
| 5 |
Royce & Associates
New York
|
+$9.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$10.4M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$7.31M |
| 3 |
Castleark Management
Chicago,
Illinois
|
-$6.43M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.64M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.67M |
MLAB Hedge Fund Activity: Q2 2020 in Review
169 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q2 2020, worth a combined $1.01B — up 7.7% from $940M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new MLAB positions and 9 closed out — a net gain of 25 holders — while 67 added to existing stakes and 35 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $21.4M. The largest seller was BlackRock, cutting an estimated $10.4M.
- 169 institutional investors held Mesa Laboratories (MLAB) as of Q2 2020, up from 144 in Q1 2020.
- Funds reported $1.01B of Mesa Laboratories stock for Q2 2020, up 7.7% quarter-over-quarter.
- 34 funds opened new Mesa Laboratories positions in Q2 2020 and 9 closed out, a net change of +25 holders.
- The largest Mesa Laboratories buyer in Q2 2020 was T. Rowe Price Associates, an estimated $21.4M added.
- The largest Mesa Laboratories seller in Q2 2020 was BlackRock, an estimated $10.4M sold.
Based on aggregated 13F filings for Q2 2020.